← Back to Search

Mobile Apps for Smoking Cessation

N/A
Waitlist Available
Led By Jennifer Minnix
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
English speaking and ability to read and comprehend English
MD Anderson patient between the ages of 18 to 65
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether the Free4Good mobile app, which teaches positive psychology skills, can help adult smokers quit smoking, compared to a control app which only offers breathing relaxation.

Who is the study for?
This trial is for adult smokers aged 18-65 who are patients at MD Anderson, have been smoking daily for at least a year, and own an iPhone with regular app usage. They must be willing to set a quit date within the next month and not be receiving other cessation treatments or suffering from severe depression or conditions that could risk their safety.
What is being tested?
The study tests two smartphone apps' effectiveness in aiding smoking cessation among participants already enrolled in a Tobacco Treatment Program. One group will use the Free4Good app focusing on positive psychology, while the control group will use Breathe2Relax, an app for breathing relaxation.
What are the potential side effects?
Since this trial involves using mobile applications as interventions without pharmaceuticals, there are no direct medical side effects expected. However, users may experience frustration or lack of satisfaction if they find the apps unhelpful.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can speak and understand English well.
Select...
I am a patient at MD Anderson, aged between 18 and 65.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Group 2 smartphone applicationsExperimental Treatment1 Intervention
app is designed to help you increase your positive feelings, behaviors, and thoughts.
Group II: Group 1 smartphone applicationsExperimental Treatment1 Intervention
app is designed to help you learn relaxation skills

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
3,070 Previous Clinical Trials
1,802,800 Total Patients Enrolled
Jennifer MinnixPrincipal InvestigatorM.D. Anderson Cancer Center

Media Library

Group 1 smartphone applications Clinical Trial Eligibility Overview. Trial Name: NCT05038852 — N/A
Smoking Cessation Research Study Groups: Group 1 smartphone applications, Group 2 smartphone applications
Smoking Cessation Clinical Trial 2023: Group 1 smartphone applications Highlights & Side Effects. Trial Name: NCT05038852 — N/A
Group 1 smartphone applications 2023 Treatment Timeline for Medical Study. Trial Name: NCT05038852 — N/A
Smoking Cessation Patient Testimony for trial: Trial Name: NCT05038852 — N/A
~1 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top